HarbourVest Partners Invests $21 Million in Generate Biomedicines
On May 15, 2026, HarbourVest Partners disclosed a new investment of approximately $21 million into Generate Biomedicines (GENB), acquiring over 1.7 million shares during the first quarter of 2026. The position now accounts for about 21% of the fund's reportable assets under management.
Tickers: $GENB
Topics: 13F Report Generate Biomedicines HarbourVest Partners SEC Filing